Currently approved viral vector-based and mRNA-based vaccine approaches against
coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After …

Secretory immunoglobulin A (SIgA) shields the gut epithelium from luminal antigens and
contributes to host-microbe symbiosis. However, how antibody responses are regulated to …

In comparison to secondary lymphoid organs, gut‐associated lymphoid tissues such as
isolated lymphoid follicles (ILF) and cryptopatches (CP) have been less intensively studied. To …

Besides Peyer’s patches, solitary intestinal lymphoid tissue (SILT) provides a structural
platform to efficiently initiate immune responses in the murine small intestine. SILT consists of …

Diarrheal diseases represent a major health burden in developing countries. Parenteral
immunization typically does not induce efficient protection against enteropathogens because it …

Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19,
ChAd) followed by an mRNA vaccine (eg BNT162b2, BNT) has been reported to be superior …

SARS-CoV-2 omicron XBB sublineages efficiently evade immunity from infection or
vaccination, requiring vaccine adaptation. Updated mono valent omicron XBB. 1.5-containing …

Since the beginning of the COVID-19 pandemic, divergent variants of concern (VoCs) of
SARS-CoV-2 have evolved and become the most prevalent SARS-CoV-2 variants in distinct …

The chemokine receptor CXCR5 is primarily expressed on B cells and Tfh cells and facilitates
their migration towards B cell follicles. In the present study we investigated the role of the …

The chemokine receptor CCR7 and its ligands CCL19 and CCL21 guide the homing and
positioning of dendritic and T cells in lymphoid organs, thereby contributing to several aspects …